ArticleCerebellum (London, England)2026
Essential Tremor Cases with Subtle Cerebellar Pathology: A Systematic Study of Postmortem Cerebellar Changes.
Article in Cerebellum (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In postmortem studies, we have identified morphologic changes centered in and around Purkinje cells (PCs) in essential tremor (ET); these are indicative of cerebellar degeneration. Recent analyses of 100 ET and 50 control cerebella demonstrated that using a combination of these cerebellar morphologic metrics, which individually measure degenerative changes, correctly predicted a diagnosis of ET or control with sensitivity and specificity ~ 95%. Among the small proportion of ET cases that were misclassified, we questioned whether there was no evidence of cerebellar degeneration, or whether the cerebellar degeneration in these cases was simply more subtle. In this study, we used the diagnostic formula previously developed by a supervised classification model to evaluate an expanded sample of 156 ET and 71 control cerebella based on 8 metrics of cerebellar pathology that fell within one of six broad categories of morphologic change. We identified 14 ET and 11 controls among whom either the pathological classification failed (7 ET, 6 controls) or in whom metric scores were close to the diagnostic cutoff (7 ET, 5 controls); these were designated as having “clinical-pathological discordance” (CPD). All 14 ET-CPD cases had elements of neurodegeneration, with the majority (11/14) showing degenerative changes in ≥ 2 metrics. Moreover, one metric, if used in isolation, correctly diagnosed 72% of these ET-CPD cases. These analyses demonstrated the presence of subtle degenerative changes in the cerebellar cortex even among ET cases who were not classified as ET using our diagnostic algorithm.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.